Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Casanova is active.

Publication


Featured researches published by J. Casanova.


European Urology Supplements | 2015

V37 Laparoscopic radical prostatectomy in intermediate and high risk prostate cancer. Indocyanine green-guided pelvic lymph node dissection

S. Valverde-Martínez; M. Ramírez-Backhaus; J. Rubio-Briones; José Domínguez-Escrig; J. Casanova; A. Gómez-Ferrer; E. Solsona-Narbón


European Urology Supplements | 2015

315 Prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program for early diagnosis of prostate cancer

J. Rubio-Briones; J. Casanova; R. Dumont; L. Rubio; A. Fernandez-Serra; I. Casanova-Salas; J. Domínguez-Escrig; M. Ramírez-Backhaus; A. Collado; A. Gómez-Ferrer; I. Iborra; J.V. Ricos; J.L. Monros; E. Solsona; D. Salas; F. Martínez; J.A. López-Guerrero


European Urology Supplements | 2010

837 PSA > 20NG/ML DOES NOT RULE OUT RADICAL PROSTATECTOMY IN HIGH RISK PATIENTS FOLLOWING NCCN CRITERIA ATTENDING METASTATIC PROGRESSION FREE SURVIVAL

J. Rubio-Briones; I. Iborra; A. Collado; A. Gómez-Ferrer; J. Casanova; J.L. Monros; J.V. Ricos; M. Trassierra; E. Solsona


European Urology Supplements | 2006

THE USEFULNESS OF F-18 DEOXIGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET) FOR RE-STAGING RENAL CELL CANCER PATIENTS WHEN A SOLITARY METASTASIS OR AN ISOLATED RENAL FOSSA RECURRENCE IS SUSPECTED

I. Iborra; E. Solsona; J.V. Ricos; J.L. Monros; R. Dumont; J. Rubio; J. Casanova; A. Collado; F. Ortega


European Urology Supplements | 2005

706Outcome of a prospective study of selected patients with muscle-invasive bladder cancer treated with radical TUR alone followed for more than 15 years

E. Solsona; I. Iborra; J.V. Ricos; J.L. Monros; J. Rubio; J. Casanova; A. Collado


European Urology Supplements | 2005

709Can late recurrences threaten the cancer-specific survival in patients with muscle-invasive bladder cancer included in bladder preservation programs?

E. Solsona; I. Iborra; J.V. Ricos; A. Collado; J. Rubio; J. Casanova; R. Dumont


European Urology Supplements | 2004

103 Reality of post radical prostatectomy erectile dysfunction treatment with sildenafil in non-selected patients

E. Solsona; I. Iborra; R. Dumont; J.V. Ricos; J. Casanova


European Urology Supplements | 2004

690 Outcome of a bladder preservation program with raical TUR and systemic chemotherapy for selected patients with invasive bladder cancer. Medium-term follow-up

E. Solsona; I. Iborra; J.V. Ricos; J.L. Monros; R. Dumont; J. Rubio; J. Casanova


European Urology Supplements | 2004

697 Risk groups of patients with bladder cancer treated with radical cystectomy alone

E. Solsona; I. Iborra; J.V. Ricos; J.L. Monros; J. Rubio; J. Casanova; R. Dumont


European Urology Supplements | 2003

The role of rescue radical cystectomy (RCT) in a bladder preservation program based on tur plus chemotherapy for patients with invasive blaader cancer

E. Solsona; I. Iborra; J.V. Ricos; J.L. Monros; R. Dumont; J. Rubio; J. Casanova

Collaboration


Dive into the J. Casanova's collaboration.

Researchain Logo
Decentralizing Knowledge